Extracorporeal shockwave therapy for Peyronie's disease: an alternative treatment?

Asian Journal of Andrology
Vassilis PoulakisEdward Becht

Abstract

To determine retrospectively the safety and efficacy of extracorporeal shock wave therapy (ESWT) in patients with Peyronie's disease. Fifty-three patients with stable Peyronie's disease underwent ESWT (group 1). Fifteen patients matched with the baseline characteristic of the patients in group 1, who received no treatment, were used as the control (group 2). The patients' erectile function (International Index of Erectile Function [IIEF-5] score), pain severity (visual analog scale), plaque size and degree of penile angulation were assessed before and after the treatment in group 1 and during the follow-up in group 2. The mean follow-up time was 32 months (range: 6-64 months) in group 1 and 35 months (range: 9-48 months) in group 2. All the patients were available for the follow-up. Considering erectile function and plaque size, no significant changes (P > 0.05) were observed in group 1 before or after the ESWT. A total of 39 patients (74%) reported a significant effect in pain relief in group 1 after ESWT. However, regarding improvement in pain, IIEF-5 score and plaque size, no significant differences were observed between the two groups. In 21 patients (40%) of group 1, the deviation angle was decreased more than 10 degrees w...Continue Reading

References

Oct 1, 1991·The Journal of Urology·M B LindsayL T Kurland
Dec 1, 1990·The Journal of Urology·M K GelbardK James
Nov 20, 1997·The Journal of Urology·L A Levine, E L Lenting
Mar 12, 2003·The Journal of Urology·Shahram S GholamiTom F Lue
Mar 18, 2003·Journal of Endourology·Maurice Stephan MichelKai Uwe Köhrmann
Jul 11, 2003·The Journal of Urology·Christoph van der HorstKlaus-Peter Juenemann
Feb 20, 2004·International Journal of Impotence Research·R T StrebelD Hauri
Mar 1, 2005·Journal of Endourology·A SkolarikosE Konstantinidis

❮ Previous
Next ❯

Citations

Jul 9, 2013·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·L FerrettiS Droupy
Jan 14, 2009·The Journal of Sexual Medicine·Alexander Müller, John P Mulhall
Jun 4, 2016·Plastic and Reconstructive Surgery. Global Open·Elliot B LanderJackie R See
Jun 3, 2016·International Journal of Impotence Research·L GaoJ Yuan
Jul 26, 2017·Nature Reviews. Urology·UNKNOWN Young Academic Urologists Men's Health GroupMaarten Albersen
Jan 24, 2019·International Journal of Impotence Research·Mikkel FodePaolo Verze
May 7, 2020·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·A OchoaM Rouprêt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.